DSDavyd V. Shabanov

Davyd V. Shabanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Davyd V. Shabanov has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    USE OF LIDOCAINE IN A MULTIMODAL ANESTHESIA PROTOCOL FOR CORONARY ARTERY BYPASS GRAFTING WITH CARDIOPULMONARY BYPASS

    by Andrii Kandybor, Davyd Shabanov, Sofiia Chaikovska, Normunds Sikora, Serhii Sudakevych, Viktor Shevchenko, Gavrylo Kovtun, Borys Todurov

    Background. According to the American Heart Association, coronary artery disease is found in a significant share of people over 60 years old, and in Ukraine it remains one of the leading causes of mortality—approximately 650 cases per 100,000 population. Most coronary artery bypass grafting (CABG) procedures are performed using cardiopulmonary bypass (CPB), which may increase the risk of complications. In this regard, we aimed to evaluate the effectiveness of lidocaine as part of a multimodal analgesia regimen during such procedures. Objective. To analyze the impact of lidocaine administration on the level of surgical stress in patients undergoing CABG with CPB by assessing fluctuations in lactate, glucose, and the pro-inflammatory cytokine IL-6. Materials and Methods. The study is based on the results of examination of 100 patients with coronary artery disease (50 patients in Group 1 — without the use of lidocaine in the multimodal anesthesia scheme; 50 patients in Group 2 — with lidocaine). All underwent CABG with cardiopulmonary bypass. Indicators were recorded at the following stages: 1)before initiation of CPB; 2) after cessation of CPB; 3) on the last day in the intensive care unit. Results and Discussion. Before the start of surgery, hemodynamic indicators suggested stable overall condition. The duration of surgery in Group 2 (with lidocaine) was shorter by 9.95% compared to Group 1 (p=0.01); anesthesia duration decreased by 8.94% (p=0.02), and CPB duration decreased by 20.06% (p=0.0003). The fentanyl dose (µg/kg/min) in Group 2 was lower by 7.3% (p=0.03), and the amount of propofol (mg) was lower by 27.8% (p=0.0002). The total dose of dobutamine in Group 2 was lower by 25.08% (p=0.02). A significant difference was also observed in the level of the pro-inflammatory cytokine IL-6. By the end of CPB, its level in Group 2 was lower by 74.4% compared to Group 1 (p=0.008). The difference in lactate level was also statistically significant — by the end of perfusion it was lower by 11.16% (p=0.04) than in the group without lidocaine. On the last day in the intensive care unit, glucose levels in Group 2 were lower by 9% compared to Group 1 (p=0.02). Duration of mechanical ventilation decreased by 27.8% (p=0.0003), and norepinephrine dosage was lower by 44.1% (p=0.03). Conclusions. In the lidocaine group, a lower requirement for Fentanyl and Propofol was observed, as well as lower values of certain early postoperative parameters, including glucose levels, duration of mechanical ventilation, and the dose of Norepinephrine. Differences in the duration of surgery, anesthesia, cardiopulmonary bypass, and intraoperative requirement for Dobutamine should be interpreted as associations rather than definitive evidence of a direct causal effect of lidocaine. To conclusively confirm the obtained results, larger prospective studies with clearly defined randomization, comprehensive inclusion and exclusion criteria, as well as correlation analysis and multivariable statistical adjustment are warranted.

  • Open Access

    Impact of Histidine-Tryptophan-Ketoglutarate Solution Dosage on Early Myocardial Protection Outcomes in Patients with Reduced Left Ventricular Ejection Fraction Undergoing Isolated Valve Surgery: A Retrospective Cohort Study

    by Davyd V. Shabanov, Stepan R. Maruniak, Serhii M. Sudakevych, Borys M. Todurov

    Introduction. Optimization of myocardial protection is a key determinant of successful cardiac surgery, particularly in patients with reduced left ventricular ejection fraction (LVEF ≤40 %), who are at increased risk of developing low cardiac output syndrome (LCOS). Despite the widespread use of histidine-tryptophan-ketoglutarate (HTK) solution, the issue of optimal dosing remains insufficiently studied.Aim. To evaluate the impact of HTK solution dose on early postoperative outcomes in patients with reduced LVEF undergoing isolated mitral valve replacement.Materials and methods. A retrospective single-center cohort study was conducted in 84 patients (mean age 59.5±8.9 years; LVEF 31.7±5.0 %). All patients underwent surgery with cardiopulmonary bypass using HTK solution. Patients were stratified according to the indexed HTK solution dose (25 mL/kg). The primary endpoint was the development of LCOS; secondary endpoints included hemodynamic parameters, biomarkers of myocardial injury, and clinical outcomes.Results. The incidence of LCOS was 21.4 % and increased significantly with higher doses (13.6 % → 34.8 %; p=0.041). Higher doses were associated with an increased vasoactive-inotropic score at weaning from cardiopulmonary bypass (9.2±3.1 → 13.1±4.2; p<0.001) and at 24 hours (8.4±3.0 → 11.8±3.9; p=0.002), as well as a greater need for inotropic support beyond 48 hours (22.7 % → 39.1 %; p=0.048). Elevated levels of troponin I and CK-MB were observed with higher doses (p<0.01). In multivariable analysis, the HTK solution dose was an independent predictor of LCOS (OR 1.12; p=0.009), along with lower LVEF and longer aortic cross-clamp time.Conclusions. Higher doses of HTK solution are associated with worse early myocardial protection outcomes in patients with reduced LVEF. These findings highlight the need for individualized cardioplegia dosing, particularly in high-risk patients.

  • Open Access

    Хірургічне лікування гігантської аневризми правої коронарної артерії, ускладненої масивним тромбозом: клінічний випадок

    by B. M. Todurov, V. O. Shevchenko, D. V. Shabanov, A. V. Markovets, I. P. Nechai, Yu. S. Spirin, V. I. Arbuzov, R. F. Mykytenko

    Coronary artery aneurysm is a relatively rare pathology that may be complicated by thrombosis, embolization, or rupture. Giant aneurysms, particularly those containing an intraluminal thrombus, are associated with a high risk of acute coronary events and require timely determination of the optimal treatment strategy.The aim – to present a clinical case of successful surgical treatment of a giant right coronary artery (RCA) aneurysm complicated by massive intraluminal thrombosis and to justify the choice of aneurysm resection with simultaneous myocardial revascularization.We describe a 68-year-old patient with comorbidities (arterial hypertension, type 2 diabetes mellitus, and dyslipidemia) who presented with progressive chest pain for three days. The initial evaluation included laboratory tests, electrocardiography, and chest radiography. Coronary angiography with ventriculography was performed to assess the coronary circulation and revealed a giant saccular aneurysm of the proximal RCA measuring up to 50 mm, with a massive thrombus within the aneurysmal cavity. Surgery was performed via median sternotomy under cardiopulmonary bypass. The procedure included coronary artery bypass grafting (to the RCA and the left anterior descending artery), opening of the aneurysm, complete removal of thrombotic masses, resection of the aneurysmal sac, and subsequent closure.Results. The postoperative period was uneventful. Follow-up echocardiography demonstrated preserved left ventricular systolic function without signs of ischemia. The patient was discharged on postoperative day 8 in stable condition with recommendations for secondary prevention and a plan for follow-up monitoring. Control computed tomography performed one month later confirmed graft patency and the absence of aneurysm recurrence. During 12 months of follow-up, the patient reported no recurrent angina and experienced no cardiovascular events.Conclusions. Giant RCA aneurysms, particularly those complicated by massive thrombosis, carry a high risk of thromboembolic complications and require an active treatment strategy. Aneurysm resection combined with coronary artery bypass grafting is an effective and safe approach that eliminates a source of embolization and provides adequate myocardial revascularization.

  • Open Access

    Analysis of the effectiveness of different cardioprotection methods in mitral valve repair in low left ventricular ejection fraction

    by D.V. Shabanov, O.A. Loskutov, B.M. Todurov

    Background. Currently, cold crystalloid cardioplegia (CCC) is used in approximately 85–90 % of cardiac surgeries requiring myocardial protection during cardiopulmonary bypass (CB). According to literature data, the rate of complications associated with this method ranges from 10 to 15 %, with the most common complications being low cardiac output syndrome and arrhythmias. The aim of our study was to analyze the effectiveness of artificial electrical fibrillation of the heart and Bretschneider solution in mitral valve repair surgeries in patients with low left ventricular (LV) ejection fraction (EF) under СВ. Materials and methods. This prospective cohort study included 97 patients with LV EF < 40 % and mitral valve stenosis or insufficiency who underwent mitral valve repair surgery at the Heart Institute of the Ministry of Health of Ukraine (Kyiv) under CB. Depending on the cardioprotection method used, all patients were divided into two groups: group A (46 people) — artificial electrical fibrillation, and group B (51 participants) — CCC using Bretschneider solution. Data collection and analysis included preoperative (anthropometric, biochemical, echocardiographic data, presence of comorbidities), intraoperative (duration of anesthesia, CB, and aortic cross-clamping, need for inotropic support), and early postoperative parameters (echocardiography, troponin I levels on the first postoperative day, and presence of rhythm disturbances). Results. Patients in group A had significantly shorter duration of anesthesia (p < 0.0001), СВ (p < 0.0001), and total aortic cross-clamping (p < 0.0001) compared to group B. On the first postoperative day, group A patients had a significantly higher troponin I level versus group B, by 33.30 ± 4.27 % (p = 0.001). Additionally, group A showed a 7.98 ± 1.44 % lower LV EF (p = 0.047) on the first postoperative day compared to group B. Furthermore, one-way ANOVA revealed a significant reduction in LV EF versus baseline values in group A during the hospital stay (p = 0.011), which was not observed in group B. Conclusions. Patients undergoing artificial electrical fibrillation exhibited significantly higher troponin I levels (by 33.30 ± 4.27 %, p = 0.001) compared to those receiving ССС, along with a significant reduction in EF compared to baseline values (p = 0.011).